All In Biotech

Drug Trial Radar · NCT06314685

Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years

A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged From 6 Months to 5 Years

Last checked: Nov 19, 2026Latest source record: Apr 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 2,450 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

2,450

Actual

Start

Dec 10, 2021

Primary completion

Aug 30, 2024

Study completion Aug 30, 2024

Sponsor

Sponsor type
Industry
First posted
Mar 18, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 6 months, up to 5 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the immunogenicity and safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.

Conditions

  • Healthy Population

Interventions

  • Group ACYW135 Meningococcal Polysaccharide Conjugate VaccineBiological

    As a experimental vaccine for 6 months to 5 years old.

  • Group A and C Meningococcal Polysaccharide VaccineBiological

    As a control vaccine for ages 6-11 months and 12-23 months.

  • Group ACYW135 Meningococcal Polysaccharide VaccineBiological

    As a control vaccine for ages 2-5 years.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Antibody positive conversion rateTime frame: 30 day after primary immunization

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hunan Center for Disease Control and Prevention

    Changsha, Hunan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.